摘要
泌尿系统感染(UTI)是临床常见的感染性疾病之一,其感染率仅次于呼吸道感染。绝经后女性是较为特殊的患者群体,其泌尿系统感染呈现病情顽固、复发率高等特点,但到目前为止的研究成果中不能较好的对绝经后女性泌尿系统感染的预防和治疗起到作用。利用近年来对绝经后女性泌尿系统感染的研究文献探讨总结了雌激素补充、乳酸杆菌、抗生素单独或联合在绝经后女性泌尿系统感染预防和治疗中的作用,并且评价这些措施的有效性和安全性。目前用来预防及治疗绝经后女性泌尿系统感染的方式还是以使用抗生素、外用雌激素为主。但是新兴的临床用药或试验用药也在进行研发和试验中,其中可能会有比较值得期待的一些干预方式。
Urinary tract infection（UTI） is one of the most common infectious diseases in the world, and the UTI rate ranks second only to that of respiratory infection. Postmenopausal women are a special population, and UTI in this population presents the features of persistence and high recurrence. So far, there have been few effective strategies available for the prevention and treatment of UTI in postmenopausal women. This paper, based on the literature, discusses the effectiveness and safety of estrogen supplementation, lactobacilli, and antibiotics, alone or in combination, in the prevention and treatment of UTI in postmenopausal women. At present, antibiotics and estrogen are the main treatments for preventing and treating UTI in postmenopausal women. However, new clinical drugs or experimental drugs are under development and trial, which may improve the treatment of UTI in postmenopausal women.
作者
王露
刘红耀
Wang Lu;Liu Hongyao(Shanxi Medical University,Taiyuan 030001,China;Department of Urology,Shanxi Academy of Medical Sciences,Shanxi Dayi Hospital,Taiyuan 030012,China)
出处
《中华临床医师杂志（电子版）》
CAS
2017年第21期2380-2382,共3页
Chinese Journal of Clinicians(Electronic Edition)
关键词
绝经后女性
泌尿系统感染
乳酸杆菌
预防
Postmenopausal women
Urinary tract infection
Lactobacillus
Prevention
